Answers are grounded in this paper and cite their sources.
Background A distinct nocebo pathway — treatment delivery failure as a generator of expectation violation and pain amplification — has received little attention despite its ubiquity in post-operative orthopedic and spinal care.Argument Cold application activates cutaneous TRPM8 receptors at temperatures below 25°C, producing genuine but modest skin-surface analgesia. However, a commonly used 20-minute icing limit in standard discharge instructions reflects frostbite prevention considerations rather than a therapeutically derived dose. In experimental studies, deeper tissue temperatures often continued to decline beyond 20 minutes of surface cooling, with substantial reductions reported during applications of 30–45 minutes, consistent with heat diffusion through tissue opposed by blood perfusion. The resulting gap between modest cutaneous analgesia and expected surgical-site relief may generate accurate negative outcome expectations of inadequate treatment effect. Conditioned through repeated applications and resistant to extinction under partial reinforcement, this delivery-failure nocebo cycle may compound the direct insufficiency of cold therapy and erode engagement with broader non-pharmacological recovery strategies.Conclusion Delivery-failure nocebo is a potentially actionable nocebo risk category, distinct from explicit verbal suggestion-mediated induction, requiring empirical verification. Correction may require improving cold therapy delivery through mechanisms not constrained by the frostbite risk of passive cold media — potentially restoring the expectation-amplified analgesic benefit that adequate cold therapy can produce — and modifying clinician communication to accurately frame the 20-minute limit as a frostbite precaution, not a therapeutic dose.
No takes yet. Share an insight, caveat, or question.
Julio L. Vergara (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: